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ABSTRACT
Context: This study is part of the Methods of Assessing
Response to Quality Improvement Strategies (MARQuIS)
research project on cross-border care, investigating
quality improvement strategies in healthcare systems
across the European Union (EU).
Aim: To explore to what extent a sample of acute care
European hospitals have implemented patient safety
strategies and mechanisms and whether the implemen-
tation is related to the type of hospital.
Methods: Data were collected on patient safety
structures and mechanisms in 389 acute care hospitals in
eight EU countries using a web-based questionnaire.
Subsequently, an on-site audit was carried out by
independent surveyors in 89 of these hospitals to assess
patient safety outputs. This paper presents univariate and
bivariate statistics on the implementation and explores
the associations between implementation of patient
safety strategies and hospital type using the x
2 test and
Fisher exact test.
Results: Structures and plans for safety (including
responsibilities regarding patient safety management) are
well developed in most of the hospitals that participated
in this study. The study found greater variation regarding
the implementation of mechanisms or activities to
promote patient safety, such as electronic drug pre-
scription systems, guidelines for prevention of wrong
patient, wrong site and wrong surgical procedure, and
adverse events reporting systems. In the sample of
hospitals that underwent audit, a considerable proportion
do not comply with basic patient safety strategies—for
example, using bracelets for adult patient identification
and correct labelling of medication.
As a result of landmark publications on patient
safety
12 and subsequent advocacy work and
research, considerable attention has focused on
improving patient safety and protecting patients.
At the international level, this includes the Global
Patient Safety Alliance launched by the World
Health Organization (WHO) and the development
of patient safety indicators within the
Organisation for Economic Co-operation and
Development (OECD) Health Care Quality
Indicator Project.
34 At the European level, the
Safety Improvement for Patients In Europe
(SIMPATIE) project aims to establish a common
European set of vocabulary, indicators, and inter-
nal and external instruments for improvement of
safety in healthcare.
5 Another European Union
(EU) project, the European Network for Patient
Safety (EUNETPAS), aims to establish an umbrella
network of all EU member states and stakeholders
to encourage and enhance collaboration in the field
of patient safety.
6 At the national level, several
European countries have launched studies on the
incidence of adverse events or initiated projects to
improve patient safety.
78Finally, several national
hospital accreditation schemes also collect data on
accomplishment of their safety standards.
However, despite the broad range of actions to
improve patient safety little information is avail-
able on the current implementation of patient
safety strategies in European hospitals.
This study was carried out within the Methods
of Assessing Response to Quality Improvement
Strategies (MARQuIS) project. The objectives of
the MARQuIS project are to describe and compare
different quality improvement policies and strate-
gies in healthcare systems across the member states
of the EU, and to consider their potential use when
patients cross borders to receive healthcare. This
research was intended to enable an evaluation of
the need for and development of formal quality
procedures at the EU level for healthcare services.
The objective of this paper was to explore the
implementation of patient safety strategies in
European hospitals and assess whether implemen-
tation was associated with type of hospital.
METHODS
We conducted an observational study in acute care
hospitals in eight European countries (Belgium,
Czech Republic, France, Ireland, Netherlands,
Poland, Spain and United Kingdom). Data for this
study was collected in two independent phases:
the first phase consisted of a self-administered,
cross-sectional survey on quality improvement
strategies in a sample of European hospitals. We
randomly selected acute hospitals with more than
100 beds that provided care for at least two out of
the three conditions covered in the study (acute
myocardial infarction, deliveries and appendicitis).
Data were collected with the MARQuIS question-
naire, a 199 issues/questions (about 500 items)
data gathering tool. The answers to this ques-
tionnaire were self-reported through a secured
internet-based application from April to August
2006. Methods and characteristics of the question-
naire, and the profile of responding hospitals, have
been described elsewhere in this supplement.
9
The second phase consisted of an on-site
external assessment in a sample of hospitals that
answered the questionnaire to test the reliability of
the self-reported responses to the questionnaire
and to collect detailed evidence of the institutio-
nalisation of quality and safety and the use of
different patient safety strategies. A purposeful
sample was defined based on the level of maturity
of the quality improvement system as determined
by a selection of questions from the MARQuIS
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10 Data were collected during a 2-day on-site
external assessment carried out by independent and specifically
trained surveyors from January to April 2007. A specific
instrument was developed for data collection (the MARQuIS
audit tool), containing a set of 341 items. For the development
of the data-gathering tools we carried out a literature research
and consultations with experts. In addition, within the
MARQuIS project, a separate research study aimed at identify-
ing particular quality and safety requirements for cross-border
patients.
11 A detailed description of the methods of the external
assessment have been discussed elsewhere in this supplement.
12
For the analysis presented in this paper we distinguished
three domains:
c Patient safety strategies: hospital-wide responsibilities
regarding patient safety management, including planning
for safety, designation of responsibilities and reporting, and
implication of leadership plans.
c Patient safety mechanisms: systems put in place by
management that have proven to increase patient safety,
such as systems for adverse event reporting or standardised
number of drugs.
c Patient safety outputs: instead of outcomes that we were not
able to collect for this study we used intermediate outputs for
patient safety strategies, based on direct observation during
on-site audit.
The presentation of data on the implementation of patient
safety strategies is based on the survey results, while the
presentation of data for patient safety mechanisms is based on
both the survey and the audit results. We calculated compliance
with patient safety strategies as the percentage of positive
responses out of the total number responses to each of the
items. For those items in the audit study with ordinal response
scales we aggregated two positive categories (exceptional and
extensive compliance). For each domain we present the
implementation in the total sample and stratified by type of
hospital (university hospital, general hospital with residency
training, general hospital without residency training). To assess
associations between implementation of patient safety strategy,
mechanisms and outputs and type of hospital we computed the
x
2 statistic and Fisher exact test. As the sample size of the audit
did not allow generalisation of results, we have not reported
data at country level.
RESULTS
A total of 389 hospitals from eight EU countries responded to
the MARQuIS questionnaire. Of these, 89 underwent an in-
depth audit. Characteristics of the participating hospitals are
presented in table 1.
Participating hospitals were mainly under public ownership
and only a small proportion of hospitals were under private
ownership, either for-profit or not-for-profit. Half of the hospitals
couldbedescribed asgeneral hospitals withresidencytrainingand
about a quarter each as university hospitals and general non-
teaching hospitals. The size of the hospitals, as assessed in terms
of the number of beds, differed considerably and ranged from
small community hospitals with fewer than 200 beds to large
university hospitals with more than 1000 beds. For all character-
istics presented here, the data in the audit sample matched the
data in the questionnaire sample of hospitals.
The analysis of structures and plans for patients’ safety and
activities performed by hospitals are reported in table 2. With
regard to structures and plans for patient safety, overall, we
observed a ceiling effect; almost all hospitals reported having
these structures and systems in place. It needs to be taken into
consideration that these results were based on self-reported
questionnaire and might have been subject to social desirability
bias. On the one hand, traditional patient safety responsibilities,
such as focus on infections and antibiotics, seemed to be better
developed than the more recent focus on patient safety as a
generic function that integrates these responsibilities. On the
other hand, the data suggested that leadership could be
improved substantially: neither the governing boards nor the
clinical committees seemed to systematically receive reports on
complications and incidence/adverse events. For all items, except
responsibilities for blood transfusion, we did not detect any
significant difference in implementation rate by type of hospital.
Moving from policies and structures (table 2) to concrete
mechanisms and activities (table 3), we found that the rates of
implementation seemed to drop, even though these data were
still based on self-reported questionnaire. Only the item
‘‘standardised and limited number of drugs’’ suggested a ceiling
effect, for the remaining items implementation was consider-
ably lower. The data suggest that systems for reporting and
analysing adverse events were more developed at departmental
than at hospital level. Despite the high frequency of wrong
patient, wrong surgery reports in the literature on adverse
events, only half of the hospitals had specific guidelines in place
to reduce such incidents. Moreover, electronic drugs prescrip-
tion systems were in place in fewer than half of the hospitals.
For these mechanisms or activities we did not detect a difference
by type of hospital.
Table 4 shows the data on the hospital audit conducted in 89
hospitals. Hospital-wide assessment was conducted for some of
the items whereas others were assessed in distinct departments.
At hospital level, the item with the highest compliance was the
use of identification bracelets for newborns. Newborn resuscita-
tion equipment was available in about 90% of the hospitals, but
given that this is basic and live-saving equipment, this rate
should not be considered as high. Surprisingly, university
hospitals reported lower rates for the availability of this
equipment, although the difference was not significant (Fisher
exact test) because of the small sample size. The two outputs
called ‘‘Data show improvement in patient safety/medication
safety after committee intervention’’ aimed to evaluate whether
hospitals monitored their safety interventions and could show
concrete improvements in relation to some of the initiatives
that had taken place. To be accepted as such, improvements
Table 1 Hospital characteristics
Characteristics
Hospital
survey Hospital audit p Value (x
2 test)
Ownership 0.325
Public 297 (80.7) 72 (81.8)
Private not-for-profit 37 (10.1) 5 (5.7)
Private for-profit 34 (9.2) 11 (12.5)
Type of hospital 0.739
University hospital 85 (23.5) 17 (19.8)
General residency training 177 (48.9) 43 (50.0)
General non-teaching 100 (27.6) 26 (30.2)
Hospital beds 0.822
,200 63 (19.1) 16 (18.6)
200–399 98 (29.7) 21 (24.4)
400–599 64 (19.4) 21 (24.4)
600–799 41 (12.4) 13 (15.1)
800–999 22 (6.7) 6 (7.0)
.999 42 (12.7) 9 (10.5)
Total 389 89
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measurement system that was used for its assessment made
explicit. For our study, any type of improvement was
acceptable, including changes in ward structure, increase in
use of bracelets, etc.
At departmental level, compliance with patient safety outputs
included in this study was only average and the data suggested
sufficient room for improvement, for example with regard to
provisionofalcoholrubdispenserstoimprovehandhygieneorthe
use of identification bracelets for adult patients. Moreover, there
did not seem to be a difference in compliance rates across
departments, except for adult patient identification by using
bracelets, which was better complied with in maternity depart-
ments. Similar to the results to the questionnaire, we could not
differentiate compliance with patient safety output by type of
hospital, either at hospital or department level.
DISCUSSION
Our study provides information about the implementation of
safety strategies and mechanisms in a sample of 389 European
hospitals, based in self-reported data and more detailed informa-
tion about outputs in 89 hospitals based on an external audit.
There are a number of limitations of the study that need to be
mentioned. First, although of great policy concern, it was not
the aim of this study to present generalisable findings at
country level with regard to the implementation of patient
safety strategies. In the context of cross-border care, all
hospitals potentially deliver services to EU citizens and an
evaluation of country differences is thus secondary. Moreover,
the differences in the rates of response to the questionnaire in
different European countries and the sample size of the audit
did not allow further stratification and generalisation. A second
limitation of the study is that it did not include outcome data
related to patient safety, owing to the limitations of the overall
research objectives, differences in data coding and availability in
the participating countries, and generally a low frequency of
patient safety events in individual hospitals. Instead, we focused
on the patient safety outputs that reflected whether systems
were fully implemented, thus providing a criterion regardless of
hospital volume or case-mix.
Table 2 Implementation of patient safety structures, responsibilities and reporting
Structure, responsibility and reporting Total yes (%) University
General with
residency
training
General
non-
teaching p Value
Structure and plan
Aims and mission include patient safety 338 (96.8) 71 (93.4) 161 (98.2) 85 (96.6) 0.179{
Designated responsibilities for:
Patient safety 255 (74.6) 58 (74.4) 120 (75.0) 57 (67.9) 0.467*
Hospital infections 349 (98.9) 80 (100.0) 161 (98.2) 88 (100.0) 0.437{
Blood transfusion 321 (94.4) 78 (98.7) 152 (96.2) 73 (88.0) 0.007{
Antibiotics 326 (93.9) 79 (98.8) 151 (93.8) 77 (90.6) 0.060{
Decubitus 295 (87.0) 62 (83.8) 143 (89.9) 70 (81.4) 0.142*
Clinical waste management 332 (95.4) 74 (93.7) 153 (95.0) 84 (96.6) 0.709{
Periodic reports on:
Patient safety 199 (92.1) 47 (92.2) 88 (89.8) 48 (94.1) 0.720{
Hospital infections 296 (98.7) 70 (100.0) 132 (99.2) 77 (96.3) 0.147{
Blood transfusion 258 (93.5) 66 (97.1) 115 (92.0) 62 (91.2) 0.322{
Antibiotics 258 (94.5) 65 (97.0) 114 (94.2) 64 (92.8) 0.529{
Decubitus 216 (88.5) 47 (88.7) 101 (89.4) 56 (88.9) 1.000{
Clinical waste management 250 (89.0) 59 (95.2) 109 (87.2) 65 (84.4) 0.111{
Implication of leadership—governing board
receives:
Report on complication registration 160 (50.5) 41 (60.3) 69 (44.2) 39 (52.0) 0.079*
Incidence/adverse events 209 (63.9) 43 (60.6) 94 (60.3) 58 (71.6) 0.196*
Implication of leadership—clinical committee
receives:
Report on complication registration 169 (63.3) 39 (69.6) 71 (56.3) 45 (66.2) 0.165*
Incidence/adverse events 198 (71.0) 38 (64.4) 89 (67.9) 56 (77.8) 0.201*
*x
2 test; {Fisher exact test.
Table 3 Patient safety mechanisms and activities (survey)
Mechanism or activity
Total yes
(%) University
General
with
residency
training
General
non-
teaching
p Value (x
2
test)
Standardised and limited number of drugs 318 (91.9) 74 (94.9) 149 (92.0) 79 (89.8) 0.478
System for reporting and analysis of adverse events
available in departments
170 (63.9) 32 (56.1) 85 (62.0) 48 (78.7) 0.101
System for reporting and analysis of adverse events
available in the hospital
174 (50.7) 36 (46.2) 69 (43.9) 54 (60.7) 0.231
Guideline/protocol for the prevention of wrong patient/
wrong surgical procedure
129 (47.1) 32 (53.3) 60 (45.5) 30 (42.9) 0.459
Electronic drug prescription system 138 (39.8) 38 (48.7) 60 (37.3) 34 (38.2) 0.215
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developed the structure and the plans needed to manage
patient safety. The designation of responsible people for the
different areas of patient safety seems widely developed,
although governing bodies and clinical representative commit-
tees are not frequently involved in the analysis of safety
monitoring data. This may mean that safety leadership is not
yet fully incorporated into the management of the organisa-
tions and safety initiatives could function somehow as a
parallel process. Regarding the main opportunities identified
for improvement related to mechanisms to promote patient
safety, it is worth noting that only 40% of the hospitals
included on this study had an electronic drug prescription
system, even though these systems have proved to be
associated with the reduction of prescription errors
13–15;as t u d y
carried out in the USA in 2004 found it was available in almost
70% of the hospitals.
16 The implementation of a guideline or
protocol for the prevention of wrong patient, wrong site and
wrong surgical procedure, currently available in fewer than half
of the hospitals, should also be reinforced. The need for this
protocol can be illustrated by the fact that surgery on the
wrong site was the most frequent type of adverse event in an
analysis by The Joint Commission in March 2008 on 4977
sentinel events, accounting for 13.1% of all adverse events.
17
Therefore, it appears that the implementation of adverse
events reporting systems in hospitals needs to be further
promoted. Although one of the issues promoted by the World
Alliance for Patient Safety from WHO
18 is focused on the
development of these systems and some of the countries
involved in this study have already developed systems at a
national level,
19–21 only 51% of the hospitals participating in the
study reported having this system available.
We did not detect any differences in the implementation of
patient safety strategies, mechanisms and outputs by hospital
type, with the exception of implementation of policies for blood
transfusion. This shows that the patient safety issues assessed
in this paper are generic in nature and should thus be
implemented irrespective of hospital type.
Despite the ceiling effect observed for some of the items, it
needs to be pointed out that that we assessed basic patient
safety strategies, mechanisms and outputs for which a growing
evidence base demonstrates effectiveness in reducing adverse
events and improving safety. For example, patient identification
by bracelet, one of the goals of the WHO Global Patient Safety
Alliance, was only poorly complied with by the hospital in our
sample.
22 Other areas to be targeted for quality improvement are
correct labelling of medication dispensed from the pharmacy
and implementation of unit-dose systems for medications.
CONCLUSION
Based on our findings it seems that patient safety structures,
activities and outputs in our sample are less developed than
those reported in US studies though more studies need to be
done to allow a generalization to European level. It seems
important to recommend further efforts to implement patients’
safety systems in European hospitals and to promote further
studies to understand its development, in particular targeting
those areas where currently compliance is still low.
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Table 4 Patient safety outputs based on hospital audit
Total yes
(%) University
General with
residency
training
General
non-
teaching p Value
Hospital-wide:
Newborn identification (ID) 74 (96.1) 12 (92.3) 39 (95.1) 20 (100.0) 0.747{
Newborn resuscitation equipment available 67 (88.2) 10 (76.9) 37 (90.2) 17 (89.5) 0.440{
Access to neonatal nursery controlled by door locks 54 (73.0) 10 (76.9) 27 (69.2) 14 (73.7) 0.848*
Medication dispensed from pharmacy is fully labelled 44 (62.0) 9 (64.3) 28 (75.7) 7 (41.2) 0.048*
Data show improvement in patient safety after committee
intervention
24 (27.9) 3 (18.8) 11 (26.8) 7 (26.9) 0.798*
Data show improvement in medication safety after
committee intervention
22 (25.0) 6 (35.3) 7 (16.7) 7 (26.9) 0.276*
Department-level:
High-risk drugs are stored separately:
Maternity 56 (74.7) 8 (66.7) 32 (80.0) 13 (65.0) 0.386*
Medicine 67 (79.8) 13 (76.5) 33 (80.5) 18 (78.3) 0.938{
Surgery 62 (73.8) 12 (75.0) 27 (69.2) 20 (76.9) 0.774*
Drugs storage locked:
Maternity 52 (70.3) 9 (69.2) 24 (61.5) 16 (84.2) 0.215*
Medicine 56 (68.3) 10 (58.8) 29 (70.7) 14 (66.7) 0.679*
Surgery 57 (67.1) 12 (70.6) 23 (59.0) 19 (76.0) 0.344*
Alcohol rub dispensers:
Maternity 49 (63.6) 8 (61.5) 25 (61.0) 13 (65.0) 0.954*
Medicine 56 (66.7) 9 (52.9) 27 (65.9) 17 (73.9) 0.385*
Surgery 54 (62.1) 9 (52.9) 26 (63.4) 16 (61.5) 0.755*
Adult patient ID:
Maternity 35 (47.3) 6 (50.0) 20 (50.0) 8 (42.1) 0.840*
Medicine 21 (25.3) 4 (23.5) 9 (22.5) 5 (21.7) 0.991*
Surgery 25 (29.1) 5 (29.4) 10 (24.4) 8 (30.8) 0.831*
*x
2 test; {Fisher exact test.
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